RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Effects of Calcium Channel Blockers On Hyaluronidaseinduced Capillary Vascular Permeability

      한글로보기

      https://www.riss.kr/link?id=A104665427

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Inflammation and increased capillary permeability is a significant aspect of the pathogenesis of many diseases including atherosclerosis. L-type calcium channel blockers (CCB) are commonly used as cardiovascular drugs. Amlodipine, lacidipine, and nica...

      Inflammation and increased capillary permeability is a significant aspect of the pathogenesis of
      many diseases including atherosclerosis. L-type calcium channel blockers (CCB) are commonly used as cardiovascular drugs. Amlodipine, lacidipine, and nicardipine were evaluated for anti-inflammatory activity on the paw oedema produced by carrageenan. The effect of these drugs was compared with the activity of indomethacin. Their effects on vascular permeability were also tested by hyaluronidase-induced capillary permeability. In our animal experiments, amlodipine decreased the carrageenan-induced paw oedema at doses of 1, 3, and 6 mg kg-1 by 27.3%, 43.7%, and 67.3% four hour after carrageenan administration; the same
      doses of lacidipine and nicardipine decreased paw oedema by 37.1%, 55.6%, 76.4%, 11.2%,
      31.0%, 91%; and indomethacin decreased oedema by 38.2% at a dose of 6 mg kg-1. Lacidipine
      significantly inhibited the hyaluronidase-induced increase in capillary permeability at
      doses of 1, 3, and 6 mg kg-1 compared with the control group. However, amlodipine and nicardipine significantly inhibited the hyaluronidase-induced increase in capillary permeability at 3 and 6 mg kg-1 doses. A 6 mg kg-1 dose of indomethacin significantly decreased the capillary permeability which was increased by hyaluronidase. These results suggest that CCBs can be efficient anti-inflammatories, and can also significantly decrease capillary permeability.

      더보기

      참고문헌 (Reference)

      1 Elferink, J. G., "The role of calcium in neutrophil migration: the effect of calcium and calcium-antagonists in electroporated neutrophils" 31 : 864-869, 1992

      2 Van Zwieten, P. A., "The pharmacological properties of lipophilic calcium antagonists" 2 : 5-9, 1998

      3 Fuster, V., "The pathogenesis of coronary artery disease and the acute coronary syndromes (2)" 326 : 310-318, 1992

      4 Sirmagul, B., "The effects of verapamil on stress- and histamine-induced gastric lesions in rats" 26 : 763-, 2004

      5 Henry, P. D., "Suppression of atherosclerosis in cholesterol-fed rabbits treated with nifedipine" 68 : 1366-1369, 1989

      6 Maslinska, D., "Some aspects of the inflammatory process" 36 : 199-204, 1998

      7 Mohler, E. R. 3rd., "Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial Prospective Randomized Amlodipine Survival Evaluation" 30 : 35-41, 1997

      8 Suleyman, H., "Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers" 58 : 692-699, 2006

      9 Siflinger-Birnboim, A., "Regulation of endothelial permeability by second messengers" 4 : 87-98, 1996

      10 Yamada, Y., "Protective effects of calcium channel blockers on hydrogen peroxide induced increases in endothelial permeability" 24 : 993-997, 1990

      1 Elferink, J. G., "The role of calcium in neutrophil migration: the effect of calcium and calcium-antagonists in electroporated neutrophils" 31 : 864-869, 1992

      2 Van Zwieten, P. A., "The pharmacological properties of lipophilic calcium antagonists" 2 : 5-9, 1998

      3 Fuster, V., "The pathogenesis of coronary artery disease and the acute coronary syndromes (2)" 326 : 310-318, 1992

      4 Sirmagul, B., "The effects of verapamil on stress- and histamine-induced gastric lesions in rats" 26 : 763-, 2004

      5 Henry, P. D., "Suppression of atherosclerosis in cholesterol-fed rabbits treated with nifedipine" 68 : 1366-1369, 1989

      6 Maslinska, D., "Some aspects of the inflammatory process" 36 : 199-204, 1998

      7 Mohler, E. R. 3rd., "Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial Prospective Randomized Amlodipine Survival Evaluation" 30 : 35-41, 1997

      8 Suleyman, H., "Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers" 58 : 692-699, 2006

      9 Siflinger-Birnboim, A., "Regulation of endothelial permeability by second messengers" 4 : 87-98, 1996

      10 Yamada, Y., "Protective effects of calcium channel blockers on hydrogen peroxide induced increases in endothelial permeability" 24 : 993-997, 1990

      11 Bilici, D., "Protective effect of T-type calcium channel blocker in histamine-induced paw inflammation in rat" 44 : 527-531, 2001

      12 Leslie, C. C., "Properties and regulation of cytosolic phospholipase A2" 272 : 16709-16712, 1997

      13 Chen, L., "Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine" 30 : 569-575, 1997

      14 Aditya, G. N., "Preliminary study on antiinflammatory effect of calcium channel blockers in albino rats" 29 : 132-134, 1997

      15 Janssen, B. J., "Preferential renal and mesenteric vasodilation induced by barnidipine and amlodipine in spontaneously hypertensive rats" 364 : 14-421, 2001

      16 Houck, J. C., "Permeability factor contaminating hyaluronidase preparations" 3 : 447-451, 1979

      17 Al-Naemi, H., "Nitric oxide protects venules against histamine-induced leaks" 7 : 215-223, 2000

      18 Libby, P., "Molecular bases of the acute coronary syndromes" 91 : 2844-2850, 1995

      19 Mason, R. P., "Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine" 31 : 275-281, 1999

      20 Kramsch, D. M., "Limits of lipid-lowering therapy: the potential benefits of amlodipine as an antiatherosclerotic agent" 62 : 119-124, 1997

      21 Siflinger-Birnboim, A., "Involvement of Ca2+ in the H2O2-induced increase in endothelial permeability" 270 : 973-978, 1996

      22 Elferink, J. G., "Interference of the calcium antagonists verapamil and nifedipine with lysosomal enzyme release from rabbit polymorphonuclear leukocytes" 32 : 1417-1420, 1982

      23 Huang, Q., "Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability" 273 : 42-2451, 1997

      24 Martinez, L. L., "Influence of verapamil and diclofenac on leukocyte migration in rats" 34 : 997-1001, 1999

      25 Chand, N., "In vitro inhibition of allergic histamine release by calcium antagonists" 107 : 353-358, 1985

      26 Liao, F., "Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice" 94 : 877-884, 1994

      27 Salomone, S., "Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery" 354 : 505-512, 1996

      28 De Souza, A. P., "Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection" 92 : 496-501, 2004

      29 Gurdal, H., "Effects of calcium channel blockers on formalin-induced nociception and inflammation in rats" 44 : 290-296, 1992

      30 Marzocco, S., "Effect of methylguanidine in carrageenaninduced acute inflammation in the rats" 26 : 341-350, 2004

      31 Pitt, B., "Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators" 102 : 1503-1151, 2000

      32 Oates, J. A., "Drugs affecting renal and cardiovascular function: Antihypertensive Agents and the Drug Therapy of Hypertension. In: Brunton L, editor. Godman and Gilman’s the pharmacological basis of therapeutics" Mc Graw-Hill 671-717, 2006

      33 Mason, R. P., "Cytoprotective properties of a long-acting calcium channel blocker: new mechanism of action" 11 : 245A-, 1998

      34 Cominacini, L., "Comparative effects of different dihydropyridines on the expression of adhesion molecules induced by TNF-alpha on endothelial cells" 17 : 1837-1841, 1999

      35 Tulenko, T. N., "Cholesterol, calcium and atherosclerosis: Is there a role forcalcium channel blockers in atheroprotection?" 62 : 55-66, 1997

      36 Winter, C. A., "Carrageenininduced edema in hind paw of the rat as an assay for antiiflammatory drugs" 111 : 544-547, 1962

      37 Carnevale, K. A., "Calcium-independent phospholipase A(2) is required for human monocyte chemotaxis to monocyte chemoattractant protein 1" 167 : 3414-3421, 2001

      38 Abernethy, D. R., "Calcium-antagonist drugs" 341 : 1447-1457, 1999

      39 Grossman, E., "Calcium antagonists" 47 : 34-57, 2004

      40 El-Bizri, N., "Bradykinin induced a positive chronotropic effect via stimulation of T- and L-type calcium currents in heart cells" 81 : 247-258, 2003

      41 Henry, P. D., "Atherosclerosis, calcium, and calcium antagonists" 72 : 456-459, 1985

      42 Ross, R., "Atherosclerosis an inflammatory disease" 340 : 115-126, 1999

      43 Kouoh, F., "Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils-a potential antiatherosclerotic property of calcium antagonists" 16 : 515-520, 2006

      44 Suleyman, H., "Antiinflammatory effect of the aqueous extract from Rumex patientia L. roots" 65 : 141-148, 1999

      45 Ramprasath, V. R., "Antiinflammatory effect of Semecarpus anacardium Linn. Nut extract in acute and chronic inflammatory conditions" 27 : 2028-2031, 2004

      46 Suleyman, H., "Antiinflammatory activity of bis(3-aryl-3-oxo-propyl)methylamine hydrochloride in rat" 30 : 63-67, 2007

      47 Suleyman, H., "Anti-inflammatory and antiulcerogenic effects of the aqueous extract of Lobaria pulmonaria (L.) Hoffm" 10 : 552-557, 2003

      48 Suleyman, H., "Anti-inflammatory activity of 3-benzoyl-1-methyl-4-phenyl-4-piperidinol hydrochloride" 47 : 471-475, 1998

      49 Procida, C., "Anti-hyaluronidase activity of some pyrazole derivatives" 47 : 159-163, 1971

      50 Neto, A. G., "Analgesic and anti-inflammatory activity of a crude root extract of Pfaffia glomerata (Spreng) Pedersen" 96 : 87-91, 2005

      51 Tulenko, T. N., "Actions of the charged dihydropyridine amlodipine in a cell culture model of dietary atherosclerosis" 126 : 11-17, 1995

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.96 0.2 1.44
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.07 0.87 0.439 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼